GHSI Guardion Health: מקדם חוב לטווח ארוך להון

Market fluctuations in Guardion Health Science (GHSI) share prices reflect a long-term debt-to-equity ratio of 0.00. The business relies on alliances with eye centers to implement specialized nutraceuticals. Strict FDA oversight and the patent protection of formulations constrain development. Meanwhile, sales expansion is yielding modest results, and investor expectations regarding new products and asset restructuring are already partially priced in.

This indicator is critically important when stress-testing debt sustainability and selecting conservative assets. The metric measures the proportion of long-term liabilities relative to equity, determining the company's degree of financial leverage. Analyzing the ratio of long-term loans to equity allows for an assessment of default risk. For Guardion Health Science (GHSI), this is particularly relevant following the divestment of its primary profit generator. Current price action reflects the process of allocating residual capital as part of the restructuring.